Mou Kejie, Abdalla Mohnad, Wei Dong Qing, Khan Muhammad Tahir, Lodhi Madeeha Shahzad, Darwish Doaa B, Sharaf Mohamed, Tu Xudong
Department of Neurosurgery, Bishan Hospital of Chongqing, Chongqing, China.
Key Laboratory of Chemical Biology (Ministry of Education), Department of Pharmaceutics, School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, 44 Cultural West Road, Shandong Province, 250012, PR China.
Inform Med Unlocked. 2021;25:100675. doi: 10.1016/j.imu.2021.100675. Epub 2021 Jul 27.
Structural proteins of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are potential drug targets due to their role in the virus life cycle. The envelope (E) protein is one of the structural proteins; plays a critical role in virulency. However, the emergence of mutations oftenly leads to drug resistance and may also play a vital role in virus stabilization and evolution. In this study, we aimed to identify mutations in E proteins that affect the protein stability. About 0.3 million complete whole genome sequences were analyzed to screen mutations in E protein. All these mutations were subjected to stability prediction using the DynaMut server. The most common mutations that were detected at the C-terminal domain, Ser68Phe, Pro71Ser, and Leu73Phe, were examined through molecular dynamics (MD) simulations for a 100ns period. The sequence analysis shows the existence of 259 mutations in E protein. Interestingly, 16 of them were detected in the DFLV amino acid (aa) motif (aa72-aa75) that binds the host PALS1 protein. The results of root mean square deviation, fluctuations, radius of gyration, and free energy landscape show that Ser68Phe, Pro71Ser, and Leu73Phe are exhibiting a more stabilizing effect. However, a more comprehensive experimental study may be required to see the effect on virus pathogenicity. Potential antiviral drugs, and vaccines may be developed used after screening the genomic variations for better management of SARS-CoV-2 infections.
严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的结构蛋白因其在病毒生命周期中的作用而成为潜在的药物靶点。包膜(E)蛋白是结构蛋白之一,在病毒毒性方面起着关键作用。然而,突变的出现常常导致耐药性,并且可能在病毒稳定和进化中也起着至关重要的作用。在本研究中,我们旨在鉴定影响E蛋白稳定性的突变。分析了约30万个完整的全基因组序列以筛选E蛋白中的突变。使用DynaMut服务器对所有这些突变进行稳定性预测。通过分子动力学(MD)模拟对在C末端结构域检测到的最常见突变Ser68Phe、Pro71Ser和Leu73Phe进行了100纳秒的研究。序列分析显示E蛋白中存在259个突变。有趣的是,其中16个在与宿主PALS1蛋白结合的DFLV氨基酸(aa)基序(aa72-aa75)中被检测到。均方根偏差、波动、回转半径和自由能景观的结果表明,Ser68Phe、Pro71Ser和Leu73Phe表现出更强的稳定作用。然而,可能需要更全面的实验研究来观察对病毒致病性的影响。在筛选基因组变异后,可开发潜在的抗病毒药物和疫苗,以更好地管理SARS-CoV-2感染。